Ex vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 phase I trial

Cancer immunology research

Volumn 2, Issue 3, 2014, Pages 229-240

  Chowdhury, F ^a   Johnson, P W ^a   Glennie, M J ^a   Williams, A P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD40 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR;

ANTAGONISTS AND INHIBITORS; ANTIGEN PRESENTING CELL; CLINICAL TRIAL; DENDRITIC CELL; DRUG ADMINISTRATION; DRUG EFFECTS; HUMAN; IMMUNOLOGY; NEOPLASMS; PHASE 1 CLINICAL TRIAL;

ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; ANTINEOPLASTIC AGENTS; CYTOKINES; DENDRITIC CELLS; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEOPLASMS; TOLL-LIKE RECEPTORS;

EID: 84921439790     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0070     Document Type: Article

References (0)